BioGenomics

BioGenomics is an India-based private biopharmaceutical company focused on diabetes and oncology, with headquarters near Mumbai/Thane and manufacturing operations in Puducherry. The company develops and manufactures biosimilar and recombinant protein products, with a pipeline centered on insulin analogs, GLP-1-based diabetes therapies, filgrastim products, and oncology monoclonal antibodies. BioGenomics emphasizes indigenous process development, including cell lines, vectors, protein engineering, purification technologies, and cGMP manufacturing. Its facilities include a DSIR-approved R&D center and WHO-GMP-certified manufacturing and fill-finish operations. In addition to therapeutic products, the company markets animal-origin-free recombinant proteins and enzymes for biopharmaceutical applications.